CD8A and myocardial infarction: In a mesenchymal stem cell transplant study, PGE2 downregulated leukocyte proliferation in-vitro, decreased the number of cytotoxic CD8+T cells in the infarcted myocardium, preserved immune privilege, and restored cardiac function post-MI [28, 29].